Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00751023Phase 4Completed
Phase 4, randomised, double-blind trial of modafinil in methamphetamine use disorder (MUD), sponsored by Medical University of South Carolina. Primary endpoint: Percentage of Participants With Methamphetamine-positive Urine Drug Screens at 5 weeks. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00751023.